1089274-75-8Relevant articles and documents
BENZIMIDAZOLE DERIVATIVES AS RLK and ITK INHIBITORS
-
, (2015/09/28)
The present disclosure is directed to certain inhibitors of RLK and ITK of formula (I), pharmaceutical compositions comprising such compounds, and method of treating diseases mediated by inhibition of RLK and ITK.
HETEROCYCLIC COMPOUNDS AND METHODS OF USE
-
Page/Page column 123, (2012/08/27)
Formula I compounds, including stereoisomers, geometric isomers, tautomers, metabolites and pharmaceutically acceptable salts thereof, are useful for inhibiting the delta isoform of PI3K, and for treating disorders mediated by lipid kinases such as inflammation, immunological disorders, and cancer. Methods of using compounds of Formula I for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.
Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
-
Page/Page column 26, (2009/01/20)
The Invention relates to compounds having an antiparasitic activity, and to their use as a drug, in particular as a drug for the prevention and/or treatment of parasitic diseases caused by apicomplexans. The invention also relates to pharmaceutical compositions containing those compounds.